Expand PMVP Menu
PMVP MENU

PMVP Stock Posts


Unusual Option Volume

PMVP PMV Pharmaceuticals1.43-0.17 (-10.6%)

PMV Pharmaceuticals trades 2,876 contracts. The company has the following event: Investor Webinar to Review Phase 2 PYNNACLE Clinical Trial Interim Analysis on Sep 10, 2025. News: PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
Unusual Option Volume

PMVP PMV Pharmaceuticals8.48+1.69 (+24.9%)

PMV Pharmaceuticals trades 2,028 contracts. The highest volume is in the 19-Jan-24 12.5 calls, which is 47.4% above the current price. News: PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights
Unusual Option Volume

PMVP PMV Pharmaceuticals10.55-0.31 (-2.9%)

PMV Pharmaceuticals trades 1,873 contracts. The company has the following event: Goldman Sachs Global Healthcare Conference on Jun 14, 2022. News: PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference
Unusual Option Volume

PMVP PMV Pharmaceuticals13.96+0.09 (+0.7%)

PMV Pharmaceuticals trades 11,380 contracts. The company has the following event: 2022 American Society of Clinical Oncology (ASCO) Annual Meeting on Jun 7, 2022. News: PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation
Unusual Option Volume

PMVP PMV Pharmaceuticals13.72-0.13 (-0.9%)

PMV Pharmaceuticals trades 4,940 contracts. The company has the following event: 2022 American Society of Clinical Oncology (ASCO) Annual Meeting on Jun 7, 2022.
Unusual Option Volume

PMVP PMV Pharmaceuticals12.69+0.96 (+8.2%)

PMV Pharmaceuticals trades 8,156 contracts. The company has the following event: 2022 American Society of Clinical Oncology (ASCO) Annual Meeting on Jun 7, 2022.
Market Data Delayed 15 Minutes